These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

521 related items for PubMed ID: 28874472

  • 1. Dehydrosqualene Desaturase as a Novel Target for Anti-Virulence Therapy against Staphylococcus aureus.
    Gao P, Davies J, Kao RYT.
    mBio; 2017 Sep 05; 8(5):. PubMed ID: 28874472
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Staphyloxanthin inhibitory potential of thymol impairs antioxidant fitness, enhances neutrophil mediated killing and alters membrane fluidity of methicillin resistant Staphylococcus aureus.
    Valliammai A, Selvaraj A, Muthuramalingam P, Priya A, Ramesh M, Pandian SK.
    Biomed Pharmacother; 2021 Sep 05; 141():111933. PubMed ID: 34328107
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Antibiofilm and staphyloxanthin inhibitory potential of terbinafine against Staphylococcus aureus: in vitro and in vivo studies.
    Askoura M, Yousef N, Mansour B, Yehia FAA.
    Ann Clin Microbiol Antimicrob; 2022 May 30; 21(1):21. PubMed ID: 35637481
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Glyceryl trinitrate blocks staphyloxanthin and biofilm formation in Staphylococcus aureus.
    Abbas HA, Elsherbini AM, Shaldam MA.
    Afr Health Sci; 2019 Mar 30; 19(1):1376-1384. PubMed ID: 31148964
    [Abstract] [Full Text] [Related]

  • 12. Beyond conventional antibiotics for the future treatment of methicillin-resistant Staphylococcus aureus infections: two novel alternatives.
    Fitzgerald-Hughes D, Devocelle M, Humphreys H.
    FEMS Immunol Med Microbiol; 2012 Aug 30; 65(3):399-412. PubMed ID: 22409572
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Discovery of Potent Benzocycloalkane Derived Diapophytoene Desaturase Inhibitors with an Enhanced Safety Profile for the Treatment of MRSA, VISA, and LRSA Infections.
    Li B, Ni S, Chen F, Mao F, Wei H, Liu Y, Zhu J, Lan L, Li J.
    ACS Infect Dis; 2018 Mar 09; 4(3):208-217. PubMed ID: 29377669
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Small-molecule compound SYG-180-2-2 attenuates Staphylococcus aureus virulence by inhibiting hemolysin and staphyloxanthin production.
    Rao L, Xu Y, Shen L, Wang X, Zhao H, Wang B, Zhang J, Xiao Y, Guo Y, Sheng Y, Cheng L, Song Z, Yu F.
    Front Cell Infect Microbiol; 2022 Mar 09; 12():1008289. PubMed ID: 36310881
    [Abstract] [Full Text] [Related]

  • 20. Pathogenicity and virulence of Staphylococcus aureus.
    Cheung GYC, Bae JS, Otto M.
    Virulence; 2021 Dec 09; 12(1):547-569. PubMed ID: 33522395
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.